Personalized ovarian cancer vaccines developed
Thursday, October 16, 2014 - 14:00
in Biology & Nature
New genomic analysis techniques were used by researchers to identify specific protein sequences, called epitopes, that the immune system can use to identify cancer cells. Their key insight was that the most effective epitopes to include in a personalized vaccine are not those that react most strongly with the immune system, but rather the epitopes that differ most from the host's normal tissue.